Yoshida Y. Developing Efficient Myocardial Reconstruction Therapy Using iPS Cells. Dubai Stem Cell Congress. Dubai, Emirate of Dubai, United Arab Emirates. February 26, 2024.
Ono K. Translational research on cardiovascular diseases targeting non-coding RNA and ATP. Yuejin Lecture in Life Sciences. Xiamen University, China. April 24, 2024.
Kato ET. Interrelationships between obesity/aging and inflammation in HFpEF. 28th Asian Pacific Society of Cardiology Congress (APSC) (invited). Dubai, Emirate of Dubai, United Arab Emirates. May 2, 2024.
Nakamura K, Murai R, Sano M, Azumi Y, Ooka J, Okada T, Toyota T, Sasaki Y, Taniguchi T, Kim K, Kobori A, Ehara N, Kinoshita M, Furukawa Y. Clinical impact of six-minute walk distance in acute heart failure patients. ESC Heart Failure 2024. Lisbon, Portugal. May 11-14, 2024.
Kato ET. Multimorbidity conditions in cardiovascular field. World Heart Federation Multiple Morbidity and Integrated Care Forum (invited). Genève, Switzerland. May 22, 2024.
Häkli M, Lucena-Cacace A, Yoshida Y. 3D Cardiac Models for Hutchinson Gilford Progeria Syndrome. EUROoCS Conference. Milan, Italy. July 3-5, 2024.
Kaneda K. Pilot Study of Online Implementation of Japanese Intensive Cardiac Rehabilitation for Post-Coronary Artery Disease Patients. Asia Prevent. Kobe, Japan. July 13, 2024.
Kato ET. Inflammation as a Therapeutic Target in Patients with Obesity. Asian Heart Society (invited). WEB. August 3, 2024.
Tamaki Y, Yaku H, Yamamoto E, Ozasa N, Inuzuka Y, Enomoto S, Miyake M, Kondo H, Tamura T, Morimoto T, Nakagawa Y, Kato T, Kimura T. Effect of renin-angiotensin system inhibitors in elderly patients with heart failure and reduced ejection fraction. European Society of Cardiology Congress (ESC) 2024. London, Britain. August 30-September 2, 2024.
Baba O. A novel VCP modulator, KUS121, attenuates atherosclerosis progression by maintaining intracellular ATP and mitigating ER stress in endothelial cells. European Society of Cardiology Congress (ESC) 2025. London, Britain. August 30-September 2, 2024.
Kaneda K. The Influence of Concomitant Antiplatelet Therapy in Venous Thromboembolism Patients Treated with Anticoagulants in the DOAC era: Insight from the COMMAND VTE Registry-2. European Society of Cardiology Congress (ESC) 2026. London, Britain. August 30-September 2, 2024.
Kaneda K. Efficacy of Online Japanese Intensive Cardiac Rehabilitation for Secondary Prevention for Coronary Artery Disease: A Comprehensive Program Including Exercise, Nutrition, Mindfulness, and Group Support. European Society of Cardiology Congress (ESC) 2027. London, Britain. August 30-September 2, 2024.
Tsujisaka Y. Clinical outcomes of edoxaban treatment without parenteral anticoagulation therapy for acute venous thromboembolism: Insight from the COMMAND VTE Registry-2. European Society of Cardiology Congress (ESC) 2028. London, Britain. August 30-September 2, 2024.
Miyoshi Y, Lucena-Cacace A, Yoshida Y. SMAD3 silencing induces Epithelial-to-Mesenchymal Transition (EMT) towards cardiac pericyte progenitors with proangiogenic potential in hiPSC-derived epicardial cells. European Society of Cardiology Congress (ESC) 2029. London, Britain. August 30-September 2, 2024.
Shimamoto K, Nishikawa R, Watanabe S, Ono K. Influence of timing of Impella insertion on the prognosis of acute myocardial infarction with cardiogenic shock requiring ECPELLA. European Society of Cardiology Congress (ESC) 2030. London, Britain. August 30-September 2, 2024.
Miura Y, Kato ET, Shiomi H, Horie T, Ono K. NBTE in Oligodendroglioma Patients: a Rare and Challenging Myocardial Infarction Presentation. European Society of Cardiology Congress (ESC) 2031. London, Britain. August 30-September 2, 2024.
Miyamoto S, Nishikimi T, Nakagawa Y. Early increase and subsequent decrease in mature BNP and early decrease and continued decrease in proBNP after sacubitril/valsartan may relate to left ventricular reverse remodeling in heart failure. European Society of Cardiology Congress (ESC) 2032. London, Britain. August 30-September 2, 2024.
Fujiwara Y, Naka Y, Sasaki M, Imahashi K, Yoshida Y. Identification of cell adhesion molecules for the maturation of engineered heart tissue. European Society of Cardiology Congress (ESC) 2033. London, Britain. August 30-September 2, 2024.
Inazuka F, Funakoshi S, Fujiwara Y, Sasaki M, Ida K, Kondo S, Imahashi K, Sakurai H, Yoshida Y. Mature cardiac tissues modeling Duchenne muscular dystrophy related cardiomyopathy. European Society of Cardiology Congress (ESC) 2034. London, Britain. August 30-September 2, 2024.
Inoue T, Tanaka M, Morinaga A, Yoneda F, Nishiwaki S, Hata R, Kojitani K, Shizuta S, Ono K. The investigation of the recurrence of blockline after cavotricuspid isthmus ablation using CT scans and a 3D mapping system. 17th Asia Pacific Heart Rhythm Society (APHRS) Scientific Sessions. Sydney, Australia. September 26-29, 2024.
Kaneda K. The Feasibility and Adherence of Online Intensive Cardiac Rehabilitation Program for Coronary Artery Disease-A pilot Study. American Heart Association Scientific Sessions 2024. Chicago, USA. November 16-18, 2024.
Yamashita Y, et al. Late-breaking science abstract：Featured Science Session/Rivaroxaban for 18 Months versus 6 Months in Cancer Patients with Low-risk Pulmonary Embolism: ONCO PE Trial. American Heart Association Scientific Sessions 2025. Chicago, USA. November 16-18, 2024.
Kato ET. Fighting Obesity to Improve CV Outcomes. APSC Cloud Forum in Cardiovascular Disease (invited). November 27, 2024.
Kato ET. Unmet Needs and Future Directions in Heart Failure. World Heart Failure Leader Meeting (invited). Denmark. December 30, 2024.